CAR T-Cell Therapy in Cancer: Balancing Efficacy with Cardiac Toxicity Concerns

Area of Science:

• Immunology
• Oncology
• Cell Therapy

Background:

• CAR-T therapy represents a novel approach to cancer treatment by modulating the immune system.
• It involves adoptive cell transfer, offering a transformative strategy for challenging cancers.

Purpose of the Study:

• To provide comprehensive information on CAR-T therapy's effectiveness across diverse cancer types.
• To compare CAR-T therapy's clinical efficacy with traditional cancer treatments.
• To review CAR-T therapy's role in both liquid and solid cancers, including response rates, durability, and limitations.

Main Methods:

• Review of CAR-T therapy's concept, structure, and function.
• Critical review of response rates, durability, and long-term effects of CAR-T methodologies.
• Analysis of CAR-T therapy in conjunction with other treatment modalities.

Main Results:

• CAR-T therapy demonstrates superior clinical effectiveness compared to surgical, radiotherapy, and immunotherapy.
• The therapy shows efficacy in liquid cancers and ongoing development for solid cancers.
• Potential for CAR-T therapies in combination with other treatments is highlighted.

Conclusions:

• CAR-T therapy is a highly effective cancer treatment strategy with impressive efficacy.
• Serious side effects, including cardiovascular toxicities and cytokine release storm (CRS), necessitate vigilant monitoring and management.
• Further investigation into long-term effects and adverse events is warranted for standardized care.